NO165679C - Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere. - Google Patents

Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere.

Info

Publication number
NO165679C
NO165679C NO861312A NO861312A NO165679C NO 165679 C NO165679 C NO 165679C NO 861312 A NO861312 A NO 861312A NO 861312 A NO861312 A NO 861312A NO 165679 C NO165679 C NO 165679C
Authority
NO
Norway
Prior art keywords
17beta
androstan
preparation
new
therapeutically effective
Prior art date
Application number
NO861312A
Other languages
English (en)
Norwegian (no)
Other versions
NO861312L (no
NO165679B (no
Inventor
Paul Haakan Andersson
Per Ture Andersson
Bengt Ingemar Axelsson
Bror Arne Thalen
Jan William Trofast
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8501692A external-priority patent/SE8501692D0/xx
Priority claimed from SE8502932A external-priority patent/SE8502932D0/xx
Application filed by Draco Ab filed Critical Draco Ab
Publication of NO861312L publication Critical patent/NO861312L/no
Priority to NO864979A priority Critical patent/NO864979L/no
Publication of NO165679B publication Critical patent/NO165679B/no
Publication of NO165679C publication Critical patent/NO165679C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO861312A 1985-04-04 1986-04-03 Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere. NO165679C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO864979A NO864979L (no) 1985-04-04 1986-12-10 Androstan-17 beta-karboksylsyreforbindelser.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8501692A SE8501692D0 (sv) 1985-04-04 1985-04-04 Novel androstane-17beta-carboxylic acid esters
SE8502932A SE8502932D0 (sv) 1985-06-13 1985-06-13 Novel androstane-17beta-carboxylic acid esters

Publications (3)

Publication Number Publication Date
NO861312L NO861312L (no) 1986-10-06
NO165679B NO165679B (no) 1990-12-10
NO165679C true NO165679C (no) 1991-03-27

Family

ID=26658930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861312A NO165679C (no) 1985-04-04 1986-04-03 Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere.

Country Status (25)

Country Link
US (1) US4804656A (es)
EP (1) EP0200692B1 (es)
JP (1) JPH0764869B2 (es)
KR (1) KR860008207A (es)
CN (1) CN86102263A (es)
AR (1) AR243535A1 (es)
AT (1) ATE67210T1 (es)
AU (1) AU594330B2 (es)
CA (1) CA1278293C (es)
CS (1) CS266580B2 (es)
DE (1) DE3681334D1 (es)
DK (1) DK165880C (es)
EG (1) EG18042A (es)
ES (1) ES8800261A1 (es)
FI (1) FI86190C (es)
GR (1) GR860901B (es)
HU (1) HU200782B (es)
IE (1) IE58309B1 (es)
IL (1) IL78144A0 (es)
MY (1) MY102057A (es)
NO (1) NO165679C (es)
NZ (1) NZ215587A (es)
PH (2) PH22578A (es)
PL (1) PL148734B1 (es)
PT (1) PT82339B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5652363A (en) * 1995-10-05 1997-07-29 C.D. Searle & Co. Pyrido-1,4-oxazinylalkyl-benzamide derivatives
KR19990076859A (ko) * 1995-12-29 1999-10-25 그레이엄 브레레톤, 레슬리 에드워즈 17.베타.-카르복시, 카르보티오 및 아미드 안드로스탄 유도체의락톤 유도체
DE69822164T2 (de) * 1997-06-30 2005-04-14 Glaxo Group Ltd., Greenford Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1517278A (en) * 1974-08-30 1978-07-12 Glaxo Lab Ltd Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
US4198336A (en) 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. Chemical process for preparing androsta-4-ene 17α-carboxylic acids
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
ZA814440B (en) * 1980-07-10 1982-10-27 Otsuka Pharma Co Ltd Soft steroids having anti-inflammatory activity
US4710495A (en) * 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
ZA817929B (en) * 1980-12-22 1982-10-27 Upjohn Co 5alpha-and 5beta-androstane-17beta-carboxylates
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters

Also Published As

Publication number Publication date
EP0200692A1 (en) 1986-11-05
CS266580B2 (en) 1990-01-12
ES553674A0 (es) 1987-11-01
AR243535A1 (es) 1993-08-31
DK138486D0 (da) 1986-03-25
PT82339A (en) 1986-05-01
IE58309B1 (en) 1993-09-08
FI86190C (fi) 1992-07-27
EG18042A (en) 1991-08-30
DE3681334D1 (de) 1991-10-17
ES8800261A1 (es) 1987-11-01
DK165880B (da) 1993-02-01
HUT41810A (en) 1987-05-28
PL148734B1 (en) 1989-11-30
GR860901B (en) 1986-07-29
EP0200692B1 (en) 1991-09-11
FI861274A (fi) 1986-10-05
NO861312L (no) 1986-10-06
AU594330B2 (en) 1990-03-08
CA1278293C (en) 1990-12-27
NZ215587A (en) 1989-08-29
MY102057A (en) 1992-03-31
CN86102263A (zh) 1987-02-04
ATE67210T1 (de) 1991-09-15
JPS61286399A (ja) 1986-12-16
AU5556686A (en) 1986-10-09
US4804656A (en) 1989-02-14
PT82339B (pt) 1988-10-14
IE860878L (en) 1986-10-04
IL78144A0 (en) 1986-07-31
HU200782B (en) 1990-08-28
PH25535A (en) 1991-07-24
FI861274A0 (fi) 1986-03-25
NO165679B (no) 1990-12-10
JPH0764869B2 (ja) 1995-07-12
KR860008207A (ko) 1986-11-14
PH22578A (en) 1988-10-17
FI86190B (fi) 1992-04-15
CS232786A2 (en) 1989-04-14
DK165880C (da) 1993-06-21
DK138486A (da) 1986-10-05

Similar Documents

Publication Publication Date Title
NO862734D0 (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
NO166123C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive asymmetriske diestere av dihydropyridindikarboksylsyrer.
NO852025L (no) Fremgangsmaate til fremstilling av 7-amino-1-cyklopropyl-6,8-dihalogen-1,4-dihydro-4-okso-3-chinolinkarboksylsyre.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO157979C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO162155C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO165679C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO863139D0 (no) Fremgangsmaate ved fremstilling av nye benzamider.
NO168041C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO165635C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater.
NO883444D0 (no) Fremgangsmaate til fremstilling av nye umettede aminosyreforbindelser.
NO161064C (no) Analogifremgangsmaate til fremstilling av fenyl-nonatetraensyrederivater.
NO865148D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO864818D0 (no) Fremgangsmaate for fremstilling av nye terapeutisk virksomme tetrahydroisokinolinderivater.
NO831012L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-beta-d-ribofuranosylselenazol-4-carboxamid
NO870482D0 (no) Fremgangsmaate ved fremstilling av nye karboksylsyreamider.